Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
This grant provides funding for developing therapies, which includes activities like improving drug compounds (medicinal chemistry), studying how drugs are processed in the body (pharmacokinetics, absorption, distribution, metabolism, excretion), assessing safety (toxicology), testing effectiveness in animals, creating biomarkers to track treatment effects, and preparing drugs according to man…
AD is the most common cause of dementia in older persons and is among the greatest healthcare challenges of the 21st century. The disease currently affects an estimated 6.7 million in the United States; by 2050, this number could rise as high as 14 million. To avert this public health crisis, ef…
Funding Source
Awards & funding
Eligibility
- Foreign eligibility: Non-domestic (non-U.S.) entities (foreign organizations) are NOT eligible to apply. However, non-domestic (non-U.S.) components of U.S. organizations are eligible to apply, and foreign components are allowed per the NIH Grants Policy Statement.
- Required regist…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers